scholarly article | Q13442814 |
P356 | DOI | 10.1016/0014-2999(77)90236-9 |
P953 | full work available at URL | https://api.elsevier.com/content/article/PII:0014299977902369?httpAccept=text/plain |
https://api.elsevier.com/content/article/PII:0014299977902369?httpAccept=text/xml | ||
P698 | PubMed publication ID | 201475 |
P2093 | author name string | B. V. Clineschmidt | |
J. C. McGuffin | |||
P2860 | cites work | Neurotensin: central nervous system effects of a hypothalamic peptide | Q41279452 |
Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes | Q43565652 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacology | Q128406 |
P304 | page(s) | 395-396 | |
P577 | publication date | 1977-12-01 | |
1977-12-15 | |||
P1433 | published in | European Journal of Pharmacology | Q1376712 |
P1476 | title | Neurotensin administered intracisternally inhibits responsiveness of mice to noxious stimuli | |
P478 | volume | 46 |
Q48403335 | Age-related changes in neurotensin content and receptors in various rat brain areas |
Q34039450 | Alterations in nociception and body temperature after intracisternal administration of neurotensin, beta-endorphin, other endogenous peptides, and morphine |
Q72718895 | Antinociceptive action of intrathecal neurotensin in mice |
Q49078139 | Antinocisponsive effects of neurotensin and neurotensin-related peptides |
Q45774676 | Behavioral analysis of the effect of neurotensin injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat. |
Q48693739 | Behavioral effects of hypothalamic hypophysiotropic hormones, neurotensin, substance P and other neuropeptides |
Q52290739 | Behavioral effects of neurotensin. |
Q90720089 | Beneficial Effects of Neurotensin in Murine Model of Hapten-Induced Asthma |
Q40085145 | Biological Perspectives in Chronic Pain, Depression, and Organic Mental Disorders |
Q72852499 | Bombesin: Receptor distribution in brain and effects on nociception and locomotor activity |
Q39453617 | Characterization of biphasic modulation of spinal nociceptive transmission by neurotensin in the rat rostral ventromedial medulla |
Q31878460 | Cold water swim stress increases the expression of neurotensin mRNA in the lateral hypothalamus and medial preoptic regions of the rat brain. |
Q36894729 | Comparative antipsychotic profiles of neurotensin and a related systemically active peptide agonist |
Q39253697 | Development of a metabolically stable neurotensin receptor 2 (NTS2) ligand |
Q70955205 | Differential neurobehavioral effects of neurotensin and structural analogues |
Q44651935 | Differential sensitivity to neurotensin-induced hypothermia, but not analgesia, in Fischer and Lewis rats |
Q48757743 | Distribution and origins of neurotensin-containing fibers in the nucleus ventromedialis hypothalami of the rat: an experimental immunohistochemical study |
Q70755638 | Distribution of NT-IR perikarya in the brain of the guinea pig with special reference to cardiovascular centers in the medulla oblongata |
Q40134265 | Distribution of neurotensin and its receptor in the central nervous system |
Q72150051 | Distribution of neurotensin-containing neurons in the central nervous system of the dog |
Q30456105 | Diverse roles of neurotensin agonists in the central nervous system |
Q49070358 | Effect of centrally administered neurotensin on multiple feeding paradigms |
Q49129426 | Effect of dorsal rhizotomy on the autoradiographic distribution of opiate and neurotensin receptors and neurotensin-like immunoreactivity within the rat spinal cord |
Q72550135 | Electrophysiological studies on the neuroactive properties of neurotensin |
Q73525799 | Highly potent neurotensin analog that causes hypothermia and antinociception |
Q34012771 | Identification and functional characterization of a stable, centrally active derivative of the neurotensin (8-13) fragment as a potential first-in-class analgesic |
Q34435669 | Identification of 1-({[1-(4-fluorophenyl)-5-(2-methoxyphenyl)-1H-pyrazol-3-yl]carbonyl}amino)cyclohexane carboxylic acid as a selective nonpeptide neurotensin receptor type 2 compound |
Q34164864 | Identification of N-[(5-{[(4-methylphenyl)sulfonyl]amino}-3-(trifluoroacetyl)-1H-indol-1-yl)acetyl]-l-leucine (NTRC-824), a neurotensin-like nonpeptide compound selective for the neurotensin receptor type 2 |
Q34977637 | Identification of N-{[6-chloro-4-(2,6-dimethoxyphenyl)quinazolin-2-yl]carbonyl}-l-leucine (NTRC-808), a novel nonpeptide chemotype selective for the neurotensin receptor type 2 |
Q88061348 | In Search of the Optimal Macrocyclization Site for Neurotensin |
Q48148694 | In vitro binding and CNS effects of novel neurotensin agonists that cross the blood-brain barrier |
Q48750625 | Interactions between neurotensin and dopamine in the brain: An overview |
Q72634344 | Neuropeptides and Monoaminergic Neurotransmitters: Their Relation to Pain |
Q42246826 | Neurotensin affects hyperactivity but not stereotypy induced by pre and post synaptic dopaminergic stimulation |
Q35152140 | Neurotensin agonists: possible drugs for treatment of psychostimulant abuse |
Q48138045 | Neurotensin and its amide analogue [Gln4]-neurotensin: effects on brain monoamine turnover |
Q34441055 | Neurotensin and the serotonergic system |
Q28580090 | Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey |
Q40273912 | Neurotensin receptors: Autoradiographic localization in rat CNS |
Q41062208 | Neurotensin-containing cell bodies, fibers and nerve terminals in the brain stem of the rat: Immunohistochemical mapping |
Q41445511 | Neurotensin: Antinocisponsive action in rodents |
Q49095946 | Neurotensin: regional distribution, characterization, and inactivation |
Q48648344 | Ontogeny of brain neurotensin in the rat: a radioimmunoassay study |
Q70259041 | Ontogeny of neurotensin-containing neuron system of the rat: Immunohistochemical analysis—II. Lower brain stem |
Q48932375 | Ontogeny of the neurotensin-containing neuron system of the rat: immunohistochemical analysis. I. Forebrain and diencephalon |
Q48620352 | Pain Threshold Changes in Rats Following Central Injection of Beta-Endorphin, Met-Enkephalin, Vasopressin or Oxytocin Antisera |
Q72742950 | Peptides and Nociception |
Q35273495 | Physiological mechanisms of the analgesic effect of neurotensin |
Q28271138 | Potent spinal analgesia elicited through stimulation of NTS2 neurotensin receptors |
Q33864641 | Radical arylation of tyrosine and its application in the synthesis of a highly selective neurotensin receptor 2 ligand |
Q27630616 | Structure of neurolysin reveals a deep channel that limits substrate access |
Q41739863 | Structure-antinociceptive activity studies with neurotensin |
Q34128818 | Systemically and topically active antinociceptive neurotensin compounds |
Q35564800 | The amide linker in nonpeptide neurotensin receptor ligands plays a key role in calcium signaling at the neurotensin receptor type 2. |
Q72694436 | The effects of centrally administered antisera to neurotensin and related peptides upon nociception and related behaviors |
Q70453163 | The effects of chronic morphine treatment on neurotensin-induced antinociception |
Q39738313 | The relationship between cardiovascular and pain regulatory systems |
Q35175664 | The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia |
Q36544566 | The role of neurotensin in central nervous system pathophysiology: what is the evidence? |
Q63608737 | Ultrastructural localization of immunoreactive neurotensin in the monkey superficial dorsal horn |
Search more.